Rapport Therapeutics, Inc.Rapport Therapeutics, Inc.Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc.

No trades
See on Supercharts

Price target

37.330.000.00%
The 3 analysts offering 1 year price forecasts for RAPP have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to RAPP in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RAPP EPS for the last quarter is −0.50 USD despite the estimation of −0.56 USD. In the next quarter EPS is expected to reach −0.64 USD. Track more of Rapport Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Rapport Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Rapport Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RAPP price target is 37.33 USD with a max estimate of 42.00 USD and a min estimate of 35.00 USD. Check if this forecast comes true in a year, meanwhile watch Rapport Therapeutics, Inc. stock price chart and keep track of the current situation with RAPP news and stock market news.